Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

This Metric Says You Are Smart to Buy COMSCORE, Inc. (SCOR)

Page 1 of 2

In today’s marketplace, there are dozens of metrics market participants can use to watch stocks. Two of the most innovative are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the top hedge fund managers can trounce their index-focused peers by a significant margin (see just how much).

Equally as key, positive insider trading sentiment is a second way to look at the investments you’re interested in. As the old adage goes: there are a variety of stimuli for an upper level exec to get rid of shares of his or her company, but only one, very obvious reason why they would behave bullishly. Several academic studies have demonstrated the impressive potential of this tactic if investors understand what to do (learn more here).


Furthermore, let’s analyze the newest info for COMSCORE, Inc. (NASDAQ:SCOR).

What have hedge funds been doing with COMSCORE, Inc. (NASDAQ:SCOR)?

At the end of the second quarter, a total of 14 of the hedge funds we track were bullish in this stock, a change of 40% from the first quarter. With the smart money’s positions undergoing their usual ebb and flow, there exists an “upper tier” of key hedge fund managers who were increasing their holdings substantially.

According to our 13F database, Cadian Capital, managed by Eric Bannasch, holds the most valuable position in COMSCORE, Inc. (NASDAQ:SCOR). Cadian Capital has a $88.4 million position in the stock, comprising 2.7% of its 13F portfolio. Coming in second is Edward Gilhuly and Scott Stuart of Sageview Capital, with a $71.2 million position; 19.3% of its 13F portfolio is allocated to the company. Other hedge funds with similar optimism include James A. Noonan’s Pivot Point Capital, Donald Chiboucis’s Columbus Circle Investors and Chuck Royce’s Royce & Associates.

As aggregate interest spiked, specific money managers were leading the bulls’ herd. Cadian Capital, managed by Eric Bannasch, assembled the largest position in COMSCORE, Inc. (NASDAQ:SCOR). Cadian Capital had 88.4 million invested in the company at the end of the quarter. Edward Gilhuly and Scott Stuart’s Sageview Capital also made a $71.2 million investment in the stock during the quarter. The other funds with brand new SCOR positions are James A. Noonan’s Pivot Point Capital, Donald Chiboucis’s Columbus Circle Investors, and Chuck Royce’s Royce & Associates.

What have insiders been doing with COMSCORE, Inc. (NASDAQ:SCOR)?

Legal insider trading, particularly when it’s bullish, is best served when the primary stock in question has experienced transactions within the past six months. Over the latest half-year time frame, COMSCORE, Inc. (NASDAQ:SCOR) has experienced zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll also review the relationship between both of these indicators in other stocks similar to COMSCORE, Inc. (NASDAQ:SCOR). These stocks are Performant Financial Corp (NASDAQ:PFMT), American Public Education, Inc. (NASDAQ:APEI), Comverse Inc (NASDAQ:CNSI), Green Dot Corporation (NYSE:GDOT), and Examworks Group, Inc. (NYSE:EXAM). This group of stocks are the members of the business services industry and their market caps are similar to SCOR’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!